Biofil Chemicals — 360° view

Biofil Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹1.67 crore and net profit of ₹0.12 crore for the September 2026 quarter.

Biofil Chemicals (NSE: BIOFILCHEM) closed at ₹29.37 on 20 Nov 2026, down 24.7% over the past year. Its market capitalisation is ₹48 crore and it trades at 91.9 times earnings.

Share price
₹29.37 (20 Nov 2026)
Market cap
₹48 Cr (20 Nov 2026)
P/E
91.89 (20 Nov 2026)
Revenue
₹2 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
2.97% (FY26)
ROE
-2.83% (FY26)
Book value
₹13.4 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹46.34 / ₹25.60 (20 Nov 2026)
1-year return
-24.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: BIOFILCHEM

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.